CN116158800B - Coronary sinus pulse saccule control method and control device - Google Patents
Coronary sinus pulse saccule control method and control device Download PDFInfo
- Publication number
- CN116158800B CN116158800B CN202310138524.6A CN202310138524A CN116158800B CN 116158800 B CN116158800 B CN 116158800B CN 202310138524 A CN202310138524 A CN 202310138524A CN 116158800 B CN116158800 B CN 116158800B
- Authority
- CN
- China
- Prior art keywords
- balloon
- gas
- pressure
- value
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003748 coronary sinus Anatomy 0.000 title claims abstract description 89
- 210000005077 saccule Anatomy 0.000 title claims 2
- 238000000034 method Methods 0.000 title abstract description 27
- 230000036772 blood pressure Effects 0.000 claims abstract description 55
- 206010053648 Vascular occlusion Diseases 0.000 abstract 1
- 208000021331 vascular occlusion disease Diseases 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 138
- 230000000903 blocking effect Effects 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- 230000008602 contraction Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 230000004217 heart function Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000035487 diastolic blood pressure Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000035488 systolic blood pressure Effects 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 2
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 2
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 2
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 2
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 2
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000004088 microvessel Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
- A61M25/10185—Valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
本发明公开了一种冠状窦脉冲球囊控制方法及控制装置,该控制方法包括:接收设定压差值和实时血压值;根据所述实时血压值计算实时压差值,所述实时压差值为所述实时血压值的平均压和预设基准压的差值;基于所述实时压差值和所述设定压差值调节球囊的充盈大小,通过以设定压差值为参数调节球囊的充盈大小能够直观得到球囊对冠状窦的封堵程度,实现对血管封堵程度的灵活控制。
The present invention discloses a coronary sinus pulse balloon control method and control device, the control method comprising: receiving a set pressure difference value and a real-time blood pressure value; calculating the real-time pressure difference value according to the real-time blood pressure value, the real-time pressure difference value being the difference between the average pressure of the real-time blood pressure value and a preset reference pressure; adjusting the filling size of the balloon based on the real-time pressure difference value and the set pressure difference value, by adjusting the filling size of the balloon with the set pressure difference value as a parameter, the degree of occlusion of the coronary sinus by the balloon can be intuitively obtained, thereby achieving flexible control of the degree of vascular occlusion.
Description
技术领域Technical Field
本发明涉及医疗器械技术领域,尤其涉及一种冠状窦脉冲球囊控制方法及控制装置。The present invention relates to the technical field of medical devices, and in particular to a coronary sinus pulse balloon control method and a control device.
背景技术Background technique
冠心病一般指冠状动脉粥样硬化性心脏病,大多冠心病患者都存在不同程度的冠脉微循环障碍(冠脉微循环障碍是指当微循环系统受到一种或多种不良因素影响出现异常时的微循环改变,主要表现为微血管中血行不畅,血流瘀滞,流态改变等等)。急性心肌梗死(AMI)临床上多有剧烈而持久的胸骨后疼痛,休息及硝酸酯类药物不能完全缓解,伴有血清心肌酶活性增高及进行性心电图变化,可并发心律失常、休克或心力衰竭,常可危及生命。Coronary heart disease generally refers to coronary atherosclerotic heart disease. Most patients with coronary heart disease have varying degrees of coronary microcirculatory disorders (coronary microcirculatory disorders refer to microcirculatory changes when the microcirculatory system is affected by one or more adverse factors and becomes abnormal, mainly manifested as poor blood flow in microvessels, blood stasis, flow pattern changes, etc.). Clinically, acute myocardial infarction (AMI) often presents with severe and persistent pain behind the sternum, which cannot be completely relieved by rest and nitrate drugs, accompanied by increased serum myocardial enzyme activity and progressive electrocardiogram changes, which may be complicated by arrhythmia, shock or heart failure, and can often be life-threatening.
冠状窦脉冲球囊是一种治疗冠心病的新型器械,冠状窦脉冲球囊基于导管球囊结构平台,通过球囊周期性封堵(或半封堵)冠状窦,实现间歇性阻碍冠状静脉血液流动,进而增加冠状窦静脉血压,以达到疏通闭塞的冠脉微血管、重塑坏死心肌的目的。目前,采用冠状窦脉冲球囊治疗已经取得了一定的临床成果。现有的冠状窦脉冲球囊为全封堵形式或半封堵形式,不同的封堵程度对治疗效果的影响,还需要更多临床数据进行量化分析,但是无论是全封堵形式或半封堵形式的冠状窦脉冲球囊,均为通过球囊的形态从而实现的封堵变化,不能实现对血管封堵程度的灵活控制。The coronary sinus pulse balloon is a new device for treating coronary heart disease. It is based on a catheter balloon structure platform. It periodically blocks (or semi-blocks) the coronary sinus with a balloon to intermittently block the blood flow in the coronary vein, thereby increasing the blood pressure in the coronary sinus vein, in order to dredge the occluded coronary microvessels and reshape the necrotic myocardium. At present, treatment with the coronary sinus pulse balloon has achieved certain clinical results. The existing coronary sinus pulse balloons are in the form of full blockage or semi-blockage. The impact of different degrees of blockage on the treatment effect requires more clinical data for quantitative analysis. However, whether it is a full blockage or semi-blockage form of the coronary sinus pulse balloon, the blockage changes are achieved through the shape of the balloon, and the degree of vascular blockage cannot be flexibly controlled.
发明内容Summary of the invention
有鉴于此,本发明实施例提供了一种冠状窦脉冲球囊控制方法及控制装置,以解决现有技术中不能对血管封堵程度的灵活控制的技术问题。In view of this, an embodiment of the present invention provides a coronary sinus pulse balloon control method and control device to solve the technical problem that the degree of blood vessel occlusion cannot be flexibly controlled in the prior art.
本发明提出的技术方案如下:The technical solution proposed by the present invention is as follows:
本发明实施例第一方面提供一种冠状窦脉冲球囊控制方法,包括:接收设定压差值和实时血压值;根据所述实时血压值计算实时压差值,所述实时压差值为所述实时血压值的平均压和预设基准压的差值;基于所述实时压差值和所述设定压差值调节球囊的充盈大小。A first aspect of an embodiment of the present invention provides a coronary sinus pulse balloon control method, comprising: receiving a set pressure difference value and a real-time blood pressure value; calculating a real-time pressure difference value based on the real-time blood pressure value, wherein the real-time pressure difference value is the difference between the average pressure of the real-time blood pressure value and a preset reference pressure; and adjusting the filling size of the balloon based on the real-time pressure difference value and the set pressure difference value.
可选地,在接收设定压差值前,包括:计算并输出所述设定压差值的调节范围。Optionally, before receiving the set pressure difference value, the method includes: calculating and outputting an adjustment range of the set pressure difference value.
可选地,所述计算并输出所述设定压差值的调节范围,包括:计算球囊完全封堵时的最大平均压;将所述最大平均压减去所述预设基准压得到调节上限,所述调节范围大于或等于零且小于或等于所述调节上限,所述预设基准压为球囊处于收缩状态下的平均压;将所述调节范围输出至显示屏进行显示。Optionally, the calculation and output of the adjustment range of the set pressure difference value includes: calculating the maximum average pressure when the balloon is completely blocked; subtracting the preset reference pressure from the maximum average pressure to obtain an upper adjustment limit, the adjustment range is greater than or equal to zero and less than or equal to the upper adjustment limit, and the preset reference pressure is the average pressure when the balloon is in a contracted state; outputting the adjustment range to a display screen for display.
可选地,冠状窦脉冲球囊控制方法还包括,计算进入球囊的气体体积,根据所述气体体积和理想气体状态方程计算球囊体积并输出。Optionally, the coronary sinus pulse balloon control method further includes calculating the volume of gas entering the balloon, calculating the balloon volume according to the gas volume and an ideal gas state equation, and outputting the calculated volume.
可选地,所述根据所述气体体积和理想气体状态方程计算球囊体积并输出,包括:获取进入球囊前的气体的第一气压值和球囊内的气体的第二气压值;获取进入球囊前的气体的第一温度值和球囊内的气体的第二温度值;将所述气体体积、第一气压值、第二气压值、第一温度值、第二温度值代入理想气体状态方程计算中间气体体积;将所述中间气体体积减去导管体积得到所述球囊体积并输出,所述导管体积为给球囊充气的管道的体积。Optionally, the calculating and outputting the balloon volume according to the gas volume and the ideal gas state equation includes: obtaining a first air pressure value of the gas before entering the balloon and a second air pressure value of the gas in the balloon; obtaining a first temperature value of the gas before entering the balloon and a second temperature value of the gas in the balloon; substituting the gas volume, the first air pressure value, the second air pressure value, the first temperature value, and the second temperature value into the ideal gas state equation to calculate the intermediate gas volume; subtracting the catheter volume from the intermediate gas volume to obtain the balloon volume and output it, wherein the catheter volume is the volume of the pipe for inflating the balloon.
本发明实施例第二方面提供了一种冠状窦脉冲球囊控制装置,包括:气路模块,用于为球囊充气和放气;血压采集模块,用于采集冠状窦内的血压值并把所述血压值发送至控制模块;所述控制模块用于执行如本发明实施例第一方面及第一方面任一项所述的冠状窦脉冲球囊控制方法。A second aspect of an embodiment of the present invention provides a coronary sinus pulse balloon control device, comprising: an air circuit module, used to inflate and deflate the balloon; a blood pressure collection module, used to collect blood pressure values in the coronary sinus and send the blood pressure values to a control module; the control module is used to execute the coronary sinus pulse balloon control method as described in the first aspect of the embodiment of the present invention and any one of the first aspects.
可选地,冠状窦脉冲球囊控制装置还包括:球囊内气压采集模块,用于采集球囊内的气体的第二气压值并把所述第二气压值发送至所述控制模块。Optionally, the coronary sinus pulse balloon control device further includes: an intra-balloon air pressure acquisition module, which is used to acquire a second air pressure value of the gas in the balloon and send the second air pressure value to the control module.
可选地,所述气路模块包括分别和所述控制模块连接的气缸、第一阀组、第一温度采集模块和第一气路压力采集模块;所述气缸用于驱动气体进入球囊;所述第一阀组用于控制气体进出通道的开闭;所述第一温度采集模块用于获取进入球囊前的气体的第一温度值;所述第一气路压力采集模块用于获取进入球囊前的气体的第一气压值。Optionally, the gas circuit module includes a cylinder, a first valve group, a first temperature acquisition module and a first gas circuit pressure acquisition module respectively connected to the control module; the cylinder is used to drive the gas into the balloon; the first valve group is used to control the opening and closing of the gas inlet and outlet channels; the first temperature acquisition module is used to obtain the first temperature value of the gas before entering the balloon; the first gas circuit pressure acquisition module is used to obtain the first air pressure value of the gas before entering the balloon.
可选地,所述控制模块还用于根据气缸的横截面积和活塞移动距离计算进入球囊的气体体积。Optionally, the control module is further used to calculate the volume of gas entering the balloon according to the cross-sectional area of the cylinder and the piston movement distance.
可选地,所述气路模块包括分别和所述控制模块连接的真空泵、第二阀组、第二温度采集模块、第二气路压力采集模块和气体流量计;所述真空泵用于驱动气体离开球囊使球囊收缩;所述第二阀组用于控制气体进出通道的开闭;所述第二温度采集模块用于获取进入球囊前的气体的第一温度值;所述第二气路压力采集模块用于获取进入球囊前的气体的第一气压值;所述气体流量计用于获取进入球囊的气体体积。Optionally, the gas circuit module includes a vacuum pump, a second valve group, a second temperature acquisition module, a second gas circuit pressure acquisition module and a gas flow meter, which are respectively connected to the control module; the vacuum pump is used to drive the gas to leave the balloon to shrink the balloon; the second valve group is used to control the opening and closing of the gas inlet and outlet channels; the second temperature acquisition module is used to obtain a first temperature value of the gas before entering the balloon; the second gas circuit pressure acquisition module is used to obtain a first air pressure value of the gas before entering the balloon; the gas flow meter is used to obtain the volume of gas entering the balloon.
从以上技术方案可以看出,本发明实施例具有以下优点:It can be seen from the above technical solutions that the embodiments of the present invention have the following advantages:
本发明实施例提供的一种冠状窦脉冲球囊控制方法及控制装置,通过接收设定压差值和实时血压值;根据所述实时血压值计算实时压差值,所述实时压差值为所述实时血压值的平均压和预设基准压的差值;基于所述实时压差值和所述设定压差值调节球囊的充盈大小,通过以设定压差值为参数调节球囊的充盈大小能够直观得到球囊对冠状窦的封堵程度,实现对血管封堵程度的灵活控制。A coronary sinus pulse balloon control method and control device provided by an embodiment of the present invention receives a set pressure difference value and a real-time blood pressure value; calculates a real-time pressure difference value according to the real-time blood pressure value, wherein the real-time pressure difference value is the difference between the average pressure of the real-time blood pressure value and a preset reference pressure; adjusts the filling size of the balloon based on the real-time pressure difference value and the set pressure difference value, and by adjusting the filling size of the balloon with the set pressure difference value as a parameter, the degree of occlusion of the coronary sinus by the balloon can be intuitively obtained, thereby achieving flexible control of the degree of blood vessel occlusion.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚地表达说明本发明实施例的技术方案,下面将对实施例描述所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly express the technical solutions of the embodiments of the present invention, the drawings required for describing the embodiments are briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
图1为本发明实施例中冠状窦脉冲球囊控制方法的流程图;FIG1 is a flow chart of a coronary sinus pulse balloon control method according to an embodiment of the present invention;
图2为本发明实施例中一闭环控制流程图;FIG2 is a closed-loop control flow chart of an embodiment of the present invention;
图3为本发明实施例中的另一闭环控制流程图;FIG3 is another closed-loop control flow chart in an embodiment of the present invention;
图4为本发明实施例中冠状窦脉冲球囊控制装置的模块框图;FIG4 is a block diagram of a coronary sinus pulse balloon control device according to an embodiment of the present invention;
图5为本发明实施例中另一冠状窦脉冲球囊控制装置的模块框图;FIG5 is a block diagram of another coronary sinus pulse balloon control device according to an embodiment of the present invention;
图6为本发明实施例中一气路模块的结构示意图;FIG6 is a schematic structural diagram of a gas path module according to an embodiment of the present invention;
图7为本发明实施例中另一冠状窦脉冲球囊控制装置的模块框图;FIG7 is a block diagram of another coronary sinus pulse balloon control device according to an embodiment of the present invention;
图8为本发明实施例中另一气路模块的结构示意图。FIG. 8 is a schematic structural diagram of another gas path module in an embodiment of the present invention.
具体实施方式Detailed ways
为了使本技术领域的人员更好地理解本发明方案,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
现有技术中,在采用球囊封堵冠状窦时,会导致短时间内冠状静脉血流无法经由冠状窦流出,如果患者心功能较弱,对冠状窦的完全封堵,患者可能无法耐受此术式、产生不良反应。半封堵式球囊好处在于,在保证一定血流的情况下,对冠状窦进行一定程度的封堵,可以避免全封堵导致的血流全阻塞,但是半封堵式球囊封堵前后的冠状窦内压力差较小,对冠脉微循环的改善效果可能产生不利影响。若术者能对封堵效果能进行灵活选择,则能针对患者心功能的强弱、血管的粗细差异,进行针对性的冠脉微循环改善性治疗。具体原理上,球囊位于冠状窦内时,逐步充盈扩张过程中,对血管封堵程度会同步升高,冠状窦内血压也会相应升高;当血管被完全封堵后,冠状窦内血压则会维持在一个相对恒定的状态;通过监控血压升高情况,即可对应得知球囊充盈程度。基于此,本发明实施例提出一种冠状窦脉冲球囊控制方法。In the prior art, when a balloon is used to block the coronary sinus, the coronary venous blood flow will not be able to flow out through the coronary sinus in a short period of time. If the patient's heart function is weak, the complete blockage of the coronary sinus may not be tolerated by the patient and may cause adverse reactions. The advantage of the semi-blocking balloon is that, while ensuring a certain blood flow, the coronary sinus is blocked to a certain extent, which can avoid the complete blockage of blood flow caused by full blockage. However, the pressure difference in the coronary sinus before and after the semi-blocking balloon blockage is small, which may have an adverse effect on the improvement of coronary microcirculation. If the surgeon can flexibly choose the blocking effect, targeted coronary microcirculation improvement treatment can be carried out according to the strength of the patient's heart function and the thickness of the blood vessels. In principle, when the balloon is located in the coronary sinus, the degree of blood vessel blockage will increase synchronously during the gradual filling and expansion process, and the blood pressure in the coronary sinus will also increase accordingly; when the blood vessel is completely blocked, the blood pressure in the coronary sinus will remain in a relatively constant state; by monitoring the increase in blood pressure, the degree of balloon filling can be known accordingly. Based on this, an embodiment of the present invention proposes a coronary sinus pulse balloon control method.
本发明实施例提供的一种冠状窦脉冲球囊控制方法,如图1所示,包括:A coronary sinus pulse balloon control method provided by an embodiment of the present invention, as shown in FIG1 , includes:
步骤S100、接收设定压差值和实时血压值。具体地,在无封堵状态下,冠状窦内实时血压会随着心脏的收缩、舒张而相应地升高、降低,对应的血压值被称作收缩压、舒张压,实时血压值包括实时收缩压和实时舒张压。设定压差值为设定平均压和预设基准压的差值,平均压也称平均动脉压,表示一个心动周期中动脉血压的平均值,平均压和收缩压、舒张压的关系为:平均压=[收缩压+(2×舒张压)]÷3。Step S100, receiving the set pressure difference value and the real-time blood pressure value. Specifically, in the unblocked state, the real-time blood pressure in the coronary sinus will increase and decrease accordingly with the contraction and relaxation of the heart. The corresponding blood pressure values are called systolic pressure and diastolic pressure. The real-time blood pressure value includes real-time systolic pressure and real-time diastolic pressure. The set pressure difference value is the difference between the set mean pressure and the preset reference pressure. The mean pressure is also called mean arterial pressure, which represents the average value of arterial blood pressure in a cardiac cycle. The relationship between the mean pressure and the systolic pressure and diastolic pressure is: mean pressure = [systolic pressure + (2 × diastolic pressure)] ÷ 3.
步骤S200、根据实时血压值计算实时压差值,实时压差值为实时血压值的平均压和预设基准压的差值。获得实时血压值根据平均压和收缩压、舒张压的关系计算实时血压值的平均压,然后将实时血压值的平均压减去预设基准压得到实时压差值。预设基准压为设置的一个参考平均压,示例性地,预设基准压为将球囊置入冠脉窦后,保持球囊的收缩状态,通过球囊导管导丝腔远端开口,持续监测10秒冠状窦内血压,得到的此时段内的血压冠状窦内平均压的均值。Step S200, calculate the real-time pressure difference value according to the real-time blood pressure value, and the real-time pressure difference value is the difference between the average pressure of the real-time blood pressure value and the preset reference pressure. The real-time blood pressure value is obtained by calculating the average pressure of the real-time blood pressure value according to the relationship between the average pressure and the systolic pressure and the diastolic pressure, and then subtracting the preset reference pressure from the average pressure of the real-time blood pressure value to obtain the real-time pressure difference value. The preset reference pressure is a set reference average pressure. Exemplarily, the preset reference pressure is to keep the balloon in a contracted state after placing the balloon into the coronary sinus, and continuously monitor the blood pressure in the coronary sinus for 10 seconds through the distal opening of the guidewire lumen of the balloon catheter, and obtain the mean value of the average pressure in the coronary sinus during this period.
步骤S300、基于实时压差值和设定压差值调节球囊的充盈大小。具体地,采用闭环控制策略,当实时压差值小于设定压差值时,则给球囊充气,增大实时压差值,当实时压差值大于设定压差值时,则给球囊放气,减小实时压差值,最终使实时压差值得大小和设定压差值大小相同。Step S300, adjusting the filling size of the balloon based on the real-time differential pressure value and the set differential pressure value. Specifically, a closed-loop control strategy is adopted, when the real-time differential pressure value is less than the set differential pressure value, the balloon is inflated to increase the real-time differential pressure value, and when the real-time differential pressure value is greater than the set differential pressure value, the balloon is deflated to reduce the real-time differential pressure value, and finally the real-time differential pressure value is equal to the set differential pressure value.
本发明实施例的一种冠状窦脉冲球囊控制方法通过接收设定压差值和实时血压值;根据实时血压值计算实时压差值,实时压差值为实时血压值的平均压和预设基准压的差值;基于实时压差值和设定压差值调节球囊的充盈大小,通过以设定压差值为参数调节球囊的充盈大小能够直观得到球囊对冠状窦的封堵程度,实现一个封堵前后的平均压差值可调的冠状窦封堵治疗,术者能依据患者的临床实际情况,灵活地调整封堵量。心功能较强者,可选择较大封堵程度,实现更为高效的微循环改善型治疗;心功能较弱者,选择较小封堵程度,实现封堵程度可调的冠状窦脉冲球囊控制,能够解决现有技术中,半封堵式、全封堵式对冠脉微循环改善型治疗带来的局限和风险,能够实现更稳妥的微循环改善型治疗。A coronary sinus pulse balloon control method according to an embodiment of the present invention receives a set pressure difference value and a real-time blood pressure value; calculates a real-time pressure difference value according to the real-time blood pressure value, and the real-time pressure difference value is the difference between the average pressure of the real-time blood pressure value and the preset reference pressure; adjusts the filling size of the balloon based on the real-time pressure difference value and the set pressure difference value, and by adjusting the filling size of the balloon with the set pressure difference value as a parameter, the degree of occlusion of the coronary sinus by the balloon can be intuitively obtained, and a coronary sinus occlusion treatment with an adjustable average pressure difference value before and after occlusion can be achieved, and the operator can flexibly adjust the occlusion amount according to the actual clinical situation of the patient. For patients with stronger heart function, a larger occlusion degree can be selected to achieve more efficient microcirculation improvement treatment; for patients with weaker heart function, a smaller occlusion degree can be selected to achieve coronary sinus pulse balloon control with adjustable occlusion degree, which can solve the limitations and risks of semi-occlusion and full occlusion in the prior art for coronary microcirculation improvement treatment, and can achieve more reliable microcirculation improvement treatment.
在一实施例中,在接收设定压差值前,包括:计算并输出设定压差值的调节范围。设定压差值的调节范围可以显示设定压差值的封堵程度,例如设定压差值处于调节范围的中间则说明球囊处于半封堵状态,设定压差值靠近调节范围的上限说明封堵程度较大等。具体地,根据设定压差值的在调节范围的位置,将设定压差值转变为对应的封堵比例,例如当设定压差值为调节范围的上限时,对应的封堵比例为100%,当设定压差值为调节范围的中间点时,对应的封堵比例为50%,通过将设定压差值用对应的封堵比例替换,可以更直观调节球囊封堵程度。封堵程度可调可以解决从而使术者能依据患者状态灵活选择冠状窦脉冲球囊的封堵程度,提高治疗效率、保证患者耐受性。In one embodiment, before receiving the set pressure difference value, it includes: calculating and outputting the adjustment range of the set pressure difference value. The adjustment range of the set pressure difference value can show the blocking degree of the set pressure difference value. For example, if the set pressure difference value is in the middle of the adjustment range, it means that the balloon is in a semi-blocked state, and if the set pressure difference value is close to the upper limit of the adjustment range, it means that the blocking degree is large. Specifically, according to the position of the set pressure difference value in the adjustment range, the set pressure difference value is converted into a corresponding blocking ratio. For example, when the set pressure difference value is the upper limit of the adjustment range, the corresponding blocking ratio is 100%, and when the set pressure difference value is the middle point of the adjustment range, the corresponding blocking ratio is 50%. By replacing the set pressure difference value with the corresponding blocking ratio, the blocking degree of the balloon can be adjusted more intuitively. The adjustable blocking degree can solve the problem so that the operator can flexibly select the blocking degree of the coronary sinus pulse balloon according to the patient's condition, improve the treatment efficiency, and ensure the patient's tolerance.
在一实施例中,计算并输出设定压差值的调节范围,包括:计算球囊完全封堵时的最大平均压;将最大平均压减去预设基准压得到调节上限,调节范围大于或等于零且小于或等于调节上限,预设基准压为球囊处于收缩状态下的平均压;将调节范围输出至显示屏进行显示。具体地,以球囊的进气动力为气缸为例,在冠状窦脉冲治疗手术准备阶段,首先控制气缸与阀组向冠状窦脉冲球囊内充气,使其缓慢充盈,充盈过程中,同步监控冠状窦内血压至平均压不再继续上升,此时,冠状窦脉冲球囊处于完全封堵状态,持续监测10秒冠状窦内血压,并将此时段内的血压冠状窦内平均压的均值定义为最大平均压。随后,控制气缸与阀组抽出冠状窦脉冲球囊内气体,使其收缩,恢复冠脉窦内血流。将最大平均压减去预设基准压,即得到设定压差值的调节上限和调节范围。将此调节范围显示在触控显示屏上,并提示术者基于患者状态,在此调节范围内选择一个预期的封堵前后平均压差值,即设定压差值。设备收到术者设置的设定压差值后,将设定压差值作为闭环控制回路的设定值,在此后的循环封堵过程中,依据此设定值,闭环控制球囊的充盈大小,从而冠状窦内封堵程度。In one embodiment, calculating and outputting the adjustment range of the set pressure difference value includes: calculating the maximum average pressure when the balloon is completely blocked; subtracting the preset reference pressure from the maximum average pressure to obtain the upper limit of the adjustment, the adjustment range is greater than or equal to zero and less than or equal to the upper limit of the adjustment, and the preset reference pressure is the average pressure of the balloon in the contracted state; and outputting the adjustment range to the display screen for display. Specifically, taking the air intake power of the balloon as an example of a cylinder, in the preparation stage of the coronary sinus pulse treatment operation, firstly control the cylinder and the valve group to inflate the coronary sinus pulse balloon to fill it slowly, and during the filling process, synchronously monitor the blood pressure in the coronary sinus until the average pressure no longer continues to rise. At this time, the coronary sinus pulse balloon is in a completely blocked state, and the blood pressure in the coronary sinus is continuously monitored for 10 seconds, and the average of the blood pressure and the average pressure in the coronary sinus during this period is defined as the maximum average pressure. Subsequently, the cylinder and the valve group are controlled to extract the gas in the coronary sinus pulse balloon to contract it and restore the blood flow in the coronary sinus. Subtracting the preset reference pressure from the maximum average pressure, the upper limit of the adjustment and the adjustment range of the set pressure difference value are obtained. This adjustment range is displayed on the touch screen, and the operator is prompted to select an expected average pressure difference before and after occlusion within this adjustment range based on the patient's condition, that is, the set pressure difference. After the device receives the set pressure difference set by the operator, it uses the set pressure difference as the set value of the closed-loop control circuit. In the subsequent cyclic occlusion process, the closed-loop controls the filling size of the balloon according to this set value, thereby adjusting the degree of occlusion in the coronary sinus.
如图2所示,在闭环控制回路中,以冠状窦内的实时血压值为被控变量,依据实时血压值计算得到实时血压值的平均压,并将实时血压值的平均压与预设基准压做减法运算,得到的结果作为反馈值传输至控制模块,控制模块将反馈值与设定值做减法运算,作为离散控制算法的输入,并根据控制算法计算结果控制气缸与第一阀组进行动作,气缸与第一阀组进行相应动作后,会使得冠状窦脉冲球囊充盈一些或是收缩一些,从而影响被控对象——冠状窦内封堵程度,最终体现为冠状窦内的实时血压值。通过闭环控制回路的周期性离散控制,冠状窦内实时血压值将会依据设定压差值达到稳态。在另一实施例中,球囊的收缩动力为真空泵,驱动球囊充盈的是装有气源的气瓶经过减压阀后的正压,气瓶自身会有一个比较高的正压,经过减压阀后,会得到一个比较小的正压,这个正压气体,使球囊充盈,此实施例中,闭环控制流程如图3所示,控制流程和气缸的控制流程相同,在此不再赘述。As shown in FIG2 , in the closed-loop control loop, the real-time blood pressure value in the coronary sinus is used as the controlled variable, and the average pressure of the real-time blood pressure value is calculated based on the real-time blood pressure value, and the average pressure of the real-time blood pressure value is subtracted from the preset reference pressure, and the result is transmitted to the control module as the feedback value. The control module subtracts the feedback value from the set value as the input of the discrete control algorithm, and controls the cylinder and the first valve group to act according to the calculation result of the control algorithm. After the cylinder and the first valve group perform corresponding actions, the coronary sinus pulse balloon will be filled or contracted, thereby affecting the controlled object - the degree of blockage in the coronary sinus, which is finally reflected in the real-time blood pressure value in the coronary sinus. Through the periodic discrete control of the closed-loop control loop, the real-time blood pressure value in the coronary sinus will reach a steady state according to the set pressure difference value. In another embodiment, the balloon's contraction power is a vacuum pump, and what drives the balloon to fill is the positive pressure of a gas cylinder containing a gas source after passing through a pressure reducing valve. The gas cylinder itself will have a relatively high positive pressure, and after passing through the pressure reducing valve, a relatively small positive pressure will be obtained. This positive pressure gas fills the balloon. In this embodiment, the closed-loop control process is shown in Figure 3, and the control process is the same as the control process of the cylinder, which will not be repeated here.
本发明实施例通过计算并显示设定压差值的调节范围,且调节范围的上限为球囊完全封堵时的最大平均压,通过对比设定压差值在调节范围的区间可以了解设定压差值对应的球囊的封堵程度,并且给用户一个明确的调节范围不会使设定压差值超出调节范围导致球囊过分充盈。The embodiment of the present invention calculates and displays the adjustment range of the set pressure difference value, and the upper limit of the adjustment range is the maximum average pressure when the balloon is completely blocked. By comparing the interval of the set pressure difference value in the adjustment range, the blocking degree of the balloon corresponding to the set pressure difference value can be understood, and a clear adjustment range is given to the user so that the set pressure difference value will not exceed the adjustment range and cause the balloon to be over-filled.
在一实施例中,冠状窦脉冲球囊控制方法还包括,计算进入球囊的气体体积,根据气体体积和理想气体状态方程计算球囊体积并输出。由于个体间差异,不同患者的冠状窦直径也存在差异,本发明实施例的冠状窦脉冲球囊控制方法可以对封堵程度闭环控制调整,很好地避免冠状窦直径的个体差异引入封堵效果的差异。但是同时,球囊体积会因为个体差异的存在、闭环控制设定值的不同而变化。所以,对球囊体积实时、精确地测算、显示可以提高术者对手术情况的掌控程度。In one embodiment, the coronary sinus pulse balloon control method further includes calculating the volume of gas entering the balloon, calculating the balloon volume according to the gas volume and the ideal gas state equation, and outputting it. Due to individual differences, the coronary sinus diameters of different patients also vary. The coronary sinus pulse balloon control method of the embodiment of the present invention can adjust the degree of occlusion through closed-loop control, and effectively avoid the difference in occlusion effect caused by individual differences in coronary sinus diameter. However, at the same time, the balloon volume will change due to individual differences and different closed-loop control setting values. Therefore, real-time and accurate measurement and display of the balloon volume can improve the surgeon's control over the surgical situation.
在一实施例中,根据气体体积和理想气体状态方程计算球囊体积并输出,包括:获取进入球囊前的气体的第一气压值和球囊内的气体的第二气压值;获取进入球囊前的气体的第一温度值和球囊内的气体的第二温度值;将气体体积、第一气压值、第二气压值、第一温度值、第二温度值代入理想气体状态方程计算中间气体体积;将中间气体体积减去导管体积得到球囊体积并输出,导管体积为给球囊充气的管道的体积。以球囊的进气动力为气缸为例,气缸为一个密封良好的活塞缸,由步进电机带动活塞进行直线运动,从而产生正负气压驱动球囊;而步进电机又由控制模块通过脉冲数精确控制。根据步进电机脉冲数、步进电机驱动器的细分数、活塞推杆的导程,即可准确计算出气缸活塞的运动位移,从而计算出气缸容积的变化量,进而依据实时气压传感器和温度传感器获取气路中进入球囊前的气体的第一气压值和第一温度值,同时设置球囊内气压采集模块采集球囊内的气体的第二气压值,第二温度值取人的体温=37℃,当然在其他实施例中也可以通过设置对应的温度传感器采集,然后利用理想气体状态方程进行相应的体积换算,获得此时球囊的体积大小,实现对冠状窦脉冲球囊体积的精确测算。In one embodiment, the balloon volume is calculated and outputted according to the gas volume and the ideal gas state equation, including: obtaining the first air pressure value of the gas before entering the balloon and the second air pressure value of the gas in the balloon; obtaining the first temperature value of the gas before entering the balloon and the second temperature value of the gas in the balloon; substituting the gas volume, the first air pressure value, the second air pressure value, the first temperature value, and the second temperature value into the ideal gas state equation to calculate the intermediate gas volume; subtracting the catheter volume from the intermediate gas volume to obtain the balloon volume and output it, and the catheter volume is the volume of the pipeline for inflating the balloon. Taking the air intake power of the balloon as an example, the cylinder is a well-sealed piston cylinder, and the piston is driven by a stepper motor to move linearly, thereby generating positive and negative air pressure to drive the balloon; and the stepper motor is precisely controlled by the control module through the number of pulses. According to the number of stepper motor pulses, the number of subdivisions of the stepper motor driver, and the lead of the piston push rod, the movement displacement of the cylinder piston can be accurately calculated, thereby calculating the change in the cylinder volume, and then according to the real-time air pressure sensor and temperature sensor, the first air pressure value and the first temperature value of the gas in the air path before entering the balloon are obtained. At the same time, the air pressure acquisition module in the balloon is set to collect the second air pressure value of the gas in the balloon, and the second temperature value is taken as the human body temperature. =37°C. Of course, in other embodiments, the temperature can be collected by setting a corresponding temperature sensor, and then the ideal gas state equation can be used to perform the corresponding volume conversion to obtain the volume of the balloon at this time, thereby achieving accurate measurement of the coronary sinus pulse balloon volume.
具体地,在气缸完成从气源抽气动作后,步进电机脉冲数为,步进电机驱动器细分数(pulse/r)为定值,电缸螺距(mm/r)为定值,设活塞移动距离为,则,设气缸直径D为定值,设抽气阶段气缸内气体体积为V1,则,第一气压值为气缸内气压,可通过压力表测得,第一温度值为气缸内气体温度可通过气体温度传感器测得。由此得到,其中为气体的物质的量,为摩尔气体常数。Specifically, after the cylinder completes the action of pumping air from the air source, the number of pulses of the stepper motor is , stepper motor driver subdivision number (pulse/r) is a fixed value, the electric cylinder pitch (mm/r) is a constant value, and the piston movement distance is ,but , assuming that the cylinder diameter D is a constant value, and the gas volume in the cylinder during the exhaust phase is V1, then , the first pressure value is the pressure in the cylinder , which can be measured by a pressure gauge. The first temperature value is the gas temperature in the cylinder It can be measured by a gas temperature sensor. ,in is the amount of gas substance, is the molar gas constant.
在气缸完成将气体泵入球囊的动作后,所有气体由气缸经由导管进入球囊,并使球囊体积膨胀。第二气压值可通过球囊内气压采集模块测得,球囊内气体温度取人的体温=37℃,设此时球囊与导管内气体总体积为。由此得到,其中为气体的物质的量,为摩尔气体常数。由物质守恒定律可得,=,可得。导管长度与横截面积在实际应用时为定值,故导管内气体体积也为定值。设球囊体积为。则,综上,可得。After the cylinder has completed the action of pumping gas into the balloon, all the gas enters the balloon through the catheter from the cylinder and expands the balloon. It can be measured by the air pressure collection module in the balloon, and the gas temperature in the balloon can be measured by the human body temperature. =37℃, assuming that the total volume of gas in the balloon and catheter is . Thus we get ,in is the amount of gas substance, is the molar gas constant. According to the law of conservation of matter, = ,Available The length and cross-sectional area of the duct are constant in practical applications, so the volume of gas in the duct is is also a constant. Assume the volume of the balloon is .but , in summary, we can get .
本发明实施例能精确测算冠状窦脉冲球囊体积,能给予术者、患者对手术过程一个更清晰、明确的了解,并且有利于对治疗效果的进一步评价分析。The embodiment of the present invention can accurately measure the volume of the coronary sinus pulse balloon, can provide the operator and the patient with a clearer and more definite understanding of the surgical process, and is conducive to further evaluation and analysis of the treatment effect.
本发明实施例还提供了一种冠状窦脉冲球囊控制装置,如图4所示,冠状窦脉冲球囊控制装置包括:The embodiment of the present invention further provides a coronary sinus pulse balloon control device, as shown in FIG4 , the coronary sinus pulse balloon control device comprises:
气路模块201,用于为球囊充气和放气。The gas circuit module 201 is used to inflate and deflate the balloon.
血压采集模块203,用于采集冠状窦内的血压值并把血压值发送至控制模块202。血压采集模块203采用有创血压检测方式,基于球囊导丝腔引出的有创血压检测通道,在球囊充盈状态、收缩状态及状态切换过程中实时检测被封堵区域的从血压值而计算有创血压平均压。The blood pressure acquisition module 203 is used to collect the blood pressure value in the coronary sinus and send the blood pressure value to the control module 202. The blood pressure acquisition module 203 adopts an invasive blood pressure detection method, based on the invasive blood pressure detection channel led out of the balloon guidewire cavity, and detects the blood pressure value of the blocked area in real time during the balloon filling state, contraction state and state switching process to calculate the invasive blood pressure average pressure.
控制模块202,用于执行如本发明任一上述实施例的冠状窦脉冲球囊控制方法。冠状窦脉冲球囊控制方法的执行过程如上述实施例,在此不做赘述。在一具体实施例中,控制模块202设置在下位机内,和上位机连接,上位机连接显示屏,显示屏具体采用触控显示屏。The control module 202 is used to execute the coronary sinus pulse balloon control method as any of the above embodiments of the present invention. The execution process of the coronary sinus pulse balloon control method is as in the above embodiments, and will not be repeated here. In a specific embodiment, the control module 202 is set in the lower computer and connected to the upper computer, and the upper computer is connected to the display screen, and the display screen is specifically a touch display screen.
本发明实施例的冠状窦脉冲球囊控制装置,控制模块202通过接收设定压差值和实时血压值;根据实时血压值计算实时压差值,实时压差值为实时血压值的平均压和预设基准压的差值;基于实时压差值和设定压差值调节球囊的充盈大小,通过以设定压差值为参数调节球囊的充盈大小能够直观得到球囊对冠状窦的封堵程度,实现一个封堵前后的平均压差值可调的冠状窦封堵治疗,术者能依据患者的临床实际情况,灵活地调整封堵量。心功能较强者,可选择较大封堵程度,实现更为高效的微循环改善型治疗;心功能较弱者,选择较小封堵程度,实现更稳妥的微循环改善型治疗。In the coronary sinus pulse balloon control device of the embodiment of the present invention, the control module 202 receives the set pressure difference value and the real-time blood pressure value; calculates the real-time pressure difference value according to the real-time blood pressure value, and the real-time pressure difference value is the difference between the average pressure of the real-time blood pressure value and the preset reference pressure; adjusts the filling size of the balloon based on the real-time pressure difference value and the set pressure difference value, and the degree of occlusion of the coronary sinus by the balloon can be intuitively obtained by adjusting the filling size of the balloon with the set pressure difference value as a parameter, so as to achieve a coronary sinus occlusion treatment with an adjustable average pressure difference value before and after occlusion, and the operator can flexibly adjust the occlusion amount according to the actual clinical situation of the patient. For patients with stronger heart function, a larger occlusion degree can be selected to achieve a more efficient microcirculation improvement treatment; for patients with weaker heart function, a smaller occlusion degree can be selected to achieve a more reliable microcirculation improvement treatment.
在一实施例中,冠状窦脉冲球囊控制装置还包括:球囊内气压采集模块,用于采集球囊内的气体的第二气压值并把第二气压值发送至控制模块202。本发明实施例能够通过球囊内气压采集模块采集球囊内的气体的第二气压值,使术者了解球囊内气压大小。In one embodiment, the coronary sinus pulse balloon control device further includes: an air pressure collection module in the balloon, which is used to collect the second air pressure value of the gas in the balloon and send the second air pressure value to the control module 202. In the embodiment of the present invention, the second air pressure value of the gas in the balloon can be collected by the air pressure collection module in the balloon, so that the operator can understand the air pressure in the balloon.
在一实施例中,如图5所示的冠状窦脉冲球囊控制装置中,气路模块201包括分别和控制模块202连接的气缸、第一阀组、第一温度采集模块和第一气路压力采集模块;气缸用于驱动气体进入球囊;第一阀组用于控制气体进出通道的开闭;第一温度采集模块用于获取进入球囊前的气体的第一温度值;第一气路压力采集模块用于获取进入球囊前的气体的第一气压值。气路模块201的作用是将气体输送至球囊,气路模块201包括多个组件,In one embodiment, in the coronary sinus pulse balloon control device shown in FIG5 , the gas circuit module 201 includes a cylinder, a first valve group, a first temperature acquisition module, and a first gas circuit pressure acquisition module respectively connected to the control module 202; the cylinder is used to drive the gas into the balloon; the first valve group is used to control the opening and closing of the gas inlet and outlet channels; the first temperature acquisition module is used to obtain the first temperature value of the gas before entering the balloon; the first gas circuit pressure acquisition module is used to obtain the first pressure value of the gas before entering the balloon. The function of the gas circuit module 201 is to deliver gas to the balloon. The gas circuit module 201 includes multiple components,
在一示例性实施例中,如图6所示,气路模块201按照进气划分可分为供气单元、脉冲动作单元和安全保护单元。In an exemplary embodiment, as shown in FIG. 6 , the gas circuit module 201 can be divided into a gas supply unit, a pulse action unit and a safety protection unit according to the gas intake.
供气单元包括依次连接的气源、第一压力表、减压阀、第二压力表、第一两通电磁阀,减压阀包括一级减压和二级减压,气源供应高压15MPa的高纯氦气或者二氧化碳气体,由第一压力表监测气体的使用量情况,并由减压阀进行减压,减压阀包括一级减压和二级减压,高压15MPa的气体经过一级减压阀可以将压力降到0.16MPa,在经过二级减压阀可以将压力降到0.014MPa。两级减压,达到系统需求压力约0.014MPa左右,并由第二压力表监控输出气体压力。The gas supply unit includes a gas source, a first pressure gauge, a pressure reducing valve, a second pressure gauge, and a first two-way solenoid valve connected in sequence. The pressure reducing valve includes a first-stage pressure reducing valve and a second-stage pressure reducing valve. The gas source supplies high-purity helium or carbon dioxide gas with a high pressure of 15MPa. The first pressure gauge monitors the gas usage and the pressure reducing valve performs pressure reduction. The pressure reducing valve includes a first-stage pressure reducing valve and a second-stage pressure reducing valve. The pressure of the high-pressure 15MPa gas can be reduced to 0.16MPa after passing through the first-stage pressure reducing valve, and can be reduced to 0.014MPa after passing through the second-stage pressure reducing valve. The two-stage pressure reducing valve reaches the system demand pressure of about 0.014MPa, and the output gas pressure is monitored by the second pressure gauge.
脉冲动作单元由气缸和步进电机组成,步进电机提供直线运动的动力,带动气缸的轴杆按照一定规律进行往复运动,从而实现脉冲球囊的充气和放气功能。The pulse action unit is composed of a cylinder and a stepper motor. The stepper motor provides the power for linear motion, driving the shaft of the cylinder to reciprocate according to a certain pattern, thereby realizing the inflation and deflation functions of the pulse balloon.
安全保护单元包括单向阀、第二两通电磁阀、安全阀、机械开关阀、第三压力表和第三两通电磁阀,单向阀和第二两通电磁阀连接,通过控制第二两通电磁阀的开闭可以实现排废气功能,安全阀可以设置一个压力上限阈值,若压力过载可以自动泄压,机械开关阀与第三压力表连接,第三压力表可以实时监控气路压力,当气路压力过载,并且安全阀也失效时,用户可以打开机械开关阀泄压,保障系统安全,以及医疗器械在手术中的安全性。The safety protection unit includes a one-way valve, a second two-way solenoid valve, a safety valve, a mechanical switch valve, a third pressure gauge and a third two-way solenoid valve. The one-way valve is connected to the second two-way solenoid valve. The exhaust gas function can be achieved by controlling the opening and closing of the second two-way solenoid valve. The safety valve can set an upper pressure threshold. If the pressure is overloaded, the pressure can be automatically released. The mechanical switch valve is connected to the third pressure gauge. The third pressure gauge can monitor the gas circuit pressure in real time. When the gas circuit pressure is overloaded and the safety valve fails, the user can open the mechanical switch valve to release the pressure to ensure the safety of the system and the safety of medical equipment during surgery.
本发明实施例中第一温度采集模块和第一气路压力采集模块安装在第三两通电磁阀和第三压力表之间,第一阀组包括供气单元、脉冲动作单元和安全保护单元中的各种阀,本发明实施例实现安全、稳定、可靠的冠状窦脉冲球囊充盈、收缩控制系统,采用气缸作为动力,在最初一个循环中,使用气源灌注气缸后,就能持续使用缸内气体控制球囊充盈、收缩,能极大减少气体用量,降低使用成本。In the embodiment of the present invention, the first temperature acquisition module and the first air path pressure acquisition module are installed between the third two-way solenoid valve and the third pressure gauge. The first valve group includes various valves in the air supply unit, the pulse action unit and the safety protection unit. The embodiment of the present invention realizes a safe, stable and reliable coronary sinus pulse balloon filling and contraction control system, and uses a cylinder as a power. In the initial cycle, after using the air source to perfuse the cylinder, the gas in the cylinder can be continuously used to control the filling and contraction of the balloon, which can greatly reduce the gas consumption and reduce the cost of use.
在一实施例中,控制模块202还用于根据气缸的横截面积和活塞移动距离计算进入球囊的气体体积。具体地,在气缸完成从气源抽气动作后,步进电机脉冲数为,步进电机驱动器细分数(pulse/r)为定值,电缸螺距(mm/r)为定值,设活塞移动距离为,则,设气缸直径D为定值,设抽气阶段气缸内气体体积为V1,则。In one embodiment, the control module 202 is further used to calculate the volume of gas entering the balloon according to the cross-sectional area of the cylinder and the piston movement distance. Specifically, after the cylinder completes the action of pumping gas from the gas source, the number of stepper motor pulses is , stepper motor driver subdivision number (pulse/r) is a fixed value, the electric cylinder pitch (mm/r) is a constant value, and the piston movement distance is ,but , assuming that the cylinder diameter D is a constant value, and the gas volume in the cylinder during the exhaust phase is V1, then .
在一实施例中,如图7所示,气路模块201包括分别和控制模块202连接的真空泵、第二阀组、第二温度采集模块、第二气路压力采集模块和气体流量计;真空泵用于驱动气体离开球囊使球囊收缩;第二阀组用于控制气体进出通道的开闭;第二温度采集模块用于获取进入球囊前的气体的第一温度值;第二气路压力采集模块用于获取进入球囊前的气体的第一气压值;气体流量计用于获取进入球囊的气体体积。In one embodiment, as shown in FIG. 7 , the gas circuit module 201 includes a vacuum pump, a second valve group, a second temperature acquisition module, a second gas circuit pressure acquisition module and a gas flow meter, which are respectively connected to the control module 202; the vacuum pump is used to drive the gas to leave the balloon to shrink the balloon; the second valve group is used to control the opening and closing of the gas inlet and outlet channels; the second temperature acquisition module is used to obtain a first temperature value of the gas before entering the balloon; the second gas circuit pressure acquisition module is used to obtain a first air pressure value of the gas before entering the balloon; and the gas flow meter is used to obtain the volume of gas entering the balloon.
如图8所示,本发明实施例的气路模块201以气体流量计与真空泵为核心单元。具体地,第二阀组在控制模块202的驱动下动作,对冠状窦脉冲球囊实现充盈、收缩控制,第二阀组包括减压阀、两位两通电磁阀、两位三通电磁阀和安全阀,减压阀用于给储存气源的气瓶减压,气源是球囊内部气体来源,为纯净、无固体颗粒杂质的标准气瓶,气体可为氦气、氮气或二氧化碳,并且气源内部绝对压力需要高于标准大气压,两位两通电磁阀为充气开关阀,两位三通电磁阀为充盈、收缩切换开关阀,安全阀用于保证气路内部压力值不超过最大耐压值。气体流量计采集进入冠状窦脉冲球囊的气体实时流量,并反馈给控制模块202,从而进行离散积分计算得到冠状窦脉冲球囊内体积,第二气路压力采集模块采集气路中相关部位的实时压力值,用于确保功能实现与安全报警。第二温度采集模块采用气体温度传感器,气体温度传感器串联在两位三通电磁阀与冠状窦脉冲球囊之间,用于检测流入冠状窦脉冲球囊的气体温度。在本实施例中,驱动球囊充盈的是装有气源的气瓶经过减压阀后的正压,气瓶自身会有一个比较高的正压,经过减压阀后,会得到一个比较小的正压,这个正压气体,使球囊充盈。真空泵与两位三通电磁阀连接,用于抽取冠状窦脉冲球囊内部的气体,排出至气体出口,从而使球囊收缩。第四压力表为机械压力表,指示当前气瓶出口压力值,同时也能反应当前气瓶剩余气量,第五压力表为电子压力表,用于监控减压阀后压力值,同时由第二气路压力采集模块将气压值传递给控制模块202,第六压力表为电子压力表,在两位三通电磁阀切换至气体流量计与冠状窦脉冲球囊时,指示当前流入球囊的气体压力,同时由第二气路压力采集模块将气压值传递给控制模块202。As shown in FIG8 , the gas circuit module 201 of the embodiment of the present invention is based on a gas flow meter and a vacuum pump as core units. Specifically, the second valve group is driven by the control module 202 to realize the filling and contraction control of the coronary sinus pulse balloon. The second valve group includes a pressure reducing valve, a two-position two-way solenoid valve, a two-position three-way solenoid valve and a safety valve. The pressure reducing valve is used to reduce the pressure of the gas cylinder storing the gas source. The gas source is the source of gas inside the balloon, which is a pure standard gas cylinder without solid particle impurities. The gas can be helium, nitrogen or carbon dioxide, and the absolute pressure inside the gas source needs to be higher than the standard atmospheric pressure. The two-position two-way solenoid valve is an inflation switch valve, the two-position three-way solenoid valve is a filling and contraction switching switch valve, and the safety valve is used to ensure that the pressure value inside the gas circuit does not exceed the maximum withstand pressure value. The gas flow meter collects the real-time flow of gas entering the coronary sinus pulse balloon and feeds it back to the control module 202, so as to perform discrete integral calculation to obtain the volume inside the coronary sinus pulse balloon. The second gas circuit pressure acquisition module collects the real-time pressure value of the relevant parts in the gas circuit to ensure function realization and safety alarm. The second temperature acquisition module uses a gas temperature sensor, which is connected in series between the two-position three-way solenoid valve and the coronary sinus pulse balloon to detect the temperature of the gas flowing into the coronary sinus pulse balloon. In this embodiment, the balloon is driven to fill with the positive pressure of the gas cylinder containing the gas source after passing through the pressure reducing valve. The gas cylinder itself will have a relatively high positive pressure. After passing through the pressure reducing valve, a relatively small positive pressure will be obtained. This positive pressure gas fills the balloon. The vacuum pump is connected to the two-position three-way solenoid valve to extract the gas inside the coronary sinus pulse balloon and discharge it to the gas outlet, thereby shrinking the balloon. The fourth pressure gauge is a mechanical pressure gauge, which indicates the current outlet pressure value of the gas cylinder and can also reflect the current remaining gas volume in the gas cylinder. The fifth pressure gauge is an electronic pressure gauge, which is used to monitor the pressure value after the pressure reducing valve. At the same time, the second gas circuit pressure acquisition module transmits the pressure value to the control module 202. The sixth pressure gauge is an electronic pressure gauge. When the two-position three-way solenoid valve is switched to the gas flow meter and the coronary sinus pulse balloon, it indicates the current gas pressure flowing into the balloon. At the same time, the second gas circuit pressure acquisition module transmits the pressure value to the control module 202.
本发明实施例实现安全、稳定、可靠的冠状窦脉冲球囊充盈、收缩控制系统,使用小体积的流量传感器和真空泵,即可实现对球囊充盈、收缩的快速控制,能显著缩减设备体积与重量,增加设备应用场景灵活性。The embodiment of the present invention realizes a safe, stable and reliable coronary sinus pulse balloon filling and contraction control system. By using a small-volume flow sensor and a vacuum pump, rapid control of balloon filling and contraction can be achieved, which can significantly reduce the size and weight of the equipment and increase the flexibility of the equipment application scenarios.
以上,以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features thereof may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310138524.6A CN116158800B (en) | 2023-02-15 | 2023-02-15 | Coronary sinus pulse saccule control method and control device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310138524.6A CN116158800B (en) | 2023-02-15 | 2023-02-15 | Coronary sinus pulse saccule control method and control device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116158800A CN116158800A (en) | 2023-05-26 |
| CN116158800B true CN116158800B (en) | 2024-07-12 |
Family
ID=86414418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310138524.6A Active CN116158800B (en) | 2023-02-15 | 2023-02-15 | Coronary sinus pulse saccule control method and control device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116158800B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116650808B (en) * | 2023-06-15 | 2025-05-16 | 天津工业大学 | Automatic balloon catheter pressure regulation and control system and method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1839765A (en) * | 2005-02-24 | 2006-10-04 | 伊西康内外科公司 | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
| CN113769246A (en) * | 2021-09-13 | 2021-12-10 | 王建 | Coronary sinus pressure regulating system |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT410396B (en) * | 2001-07-17 | 2003-04-25 | Mohl Werner Ddr | DEVICE FOR THE INTERMITTENT OCCLUSION OF THE CORONARY SINE |
| US6746465B2 (en) * | 2001-12-14 | 2004-06-08 | The Regents Of The University Of California | Catheter based balloon for therapy modification and positioning of tissue |
| US11337707B2 (en) * | 2010-05-25 | 2022-05-24 | Miracor Medical Sa | Treating heart tissue |
| CN102512225B (en) * | 2011-12-31 | 2013-05-15 | 重庆邮电大学 | An intelligent control device and method for femoral artery blood flow |
| CN104688209A (en) * | 2013-12-04 | 2015-06-10 | 乐普(北京)医疗器械股份有限公司 | Invasive blood pressure detecting and analyzing method and system |
| CN107101776B (en) * | 2017-06-19 | 2020-01-21 | 深圳市沃特沃德股份有限公司 | Force measuring method and device and force measuring device |
| CN108378618B (en) * | 2018-04-04 | 2024-03-01 | 浙江想能睡眠科技股份有限公司 | Independently maintained soft and hard adjustable mattress and control method thereof |
| CN109288548A (en) * | 2018-08-29 | 2019-02-01 | 合肥德铭电子有限公司 | Self-referral pneumoperitoneum with pneumoperitoneum flow control |
| EP4129223A4 (en) * | 2020-03-31 | 2024-04-17 | Toray Industries, Inc. | Balloon ablation catheter system and method for controlling same |
| CN113967316A (en) * | 2021-11-22 | 2022-01-25 | 山东瑞安泰医疗技术有限公司 | Implanted aorta counterpulsation device with pressure sensing automatic regulation and control function |
| CN114886495B (en) * | 2022-01-11 | 2026-01-09 | 武汉拓扑转化医学研究中心有限公司 | Pressure-controlled intermittent coronary sinus occlusion device |
| CN115120849B (en) * | 2022-08-01 | 2025-12-12 | 首都医科大学附属北京安贞医院 | A venous graft vasodilator |
-
2023
- 2023-02-15 CN CN202310138524.6A patent/CN116158800B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1839765A (en) * | 2005-02-24 | 2006-10-04 | 伊西康内外科公司 | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
| CN113769246A (en) * | 2021-09-13 | 2021-12-10 | 王建 | Coronary sinus pressure regulating system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116158800A (en) | 2023-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1061967B1 (en) | Pressure control system for cardiac assist device | |
| US5218968A (en) | Peripheral arterial monitoring instruments | |
| EP2448474B1 (en) | Devices for remote ischemic preconditioning and near-continuous blood pressure monitoring | |
| JP3114187B2 (en) | Serial left ventricular assist device | |
| EP1058512B1 (en) | External blood pressure sensor apparatus | |
| US7544167B2 (en) | Method and system for cuff pressure reversions | |
| US20020099409A1 (en) | High efficiency external counterpulsation apparatus and method for controlling same | |
| US7678059B2 (en) | Non-invasive blood pressure monitor with improved performance | |
| Nakagawara et al. | A portable instrument for non-invasive monitoring of beat-by-beat cardiovascular haemodynamic parameters based on the volume-compensation and electrical-admittance method | |
| JPH06292721A (en) | External counter pulsation device of high efficiency and its control method | |
| CN111481253B (en) | Air bag type artery compression hemostasis control system and matched equipment thereof | |
| GB2440433A (en) | Limb compression system with blood pressure monitoring | |
| CN116158800B (en) | Coronary sinus pulse saccule control method and control device | |
| CN118415864A (en) | Data analysis and monitoring method and system of external counterpulsation device | |
| CN115282469B (en) | Aortic dual-balloon driven counterpulsation catheter device | |
| US20090048481A1 (en) | Method and apparatus for improving circulation and treating erectile dysfunction | |
| CN120000507B (en) | Intermittent inflation pressure device and control method based on blood flow velocity | |
| JPH03280969A (en) | Driving control device of intra-aortic balloon | |
| CN121265974A (en) | Air supply method and air supply system for pulsating ventricular assist device | |
| WO2022266371A1 (en) | Implantable vascular shunt with real-time precise flow control | |
| KR20190123114A (en) | Capsule type enhanced external counter pulsation machine with high concentrated oxygen supply chamber |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |